Member Info for Paul0410

Ginge - I agree entirely about the nonsense posted. You've got to wonder why the usual suspects - Wyndrum and co - post relentlessly every day when there is actually nothing substantial to post about. Well you don't really have to wonder as their ploy is obvious.

Viking said "Whats to stop a steady daily drip down to who nows where, its just a constant disappointment no sign on the development of diagnostic LFTs."
What an inane comment. How can all of the recent positive news be seen by anyone as a disappointment?! It amazes me across various LSE boards and especially this one how armchair chief execs (Wyndrum as a perfect example) say that the company should do this and should do that. When the most that they've probably run in their lives is a bath! And regarding drift in the SP, so what. It seems to me that way too many people must be happy to lose money on a quick punt when instant profit doesn't arise and then sell up again. More the fool them. But that is the only reason for SP drift. The company can't and shouldn't be expected to relentlessly churn out news simply to keep the fickle interested.

Star Bright said-

"How - in practice - do proper II’s buy shares in companies that are new names in their portfolios? Here’s a brief illustration of the typical steps involved:

- Idea generation (perhaps prompted by an event like SD)
- Validation (“Is this one of the ideas we want to pursue?”)
- Due diligence (what needs to be verified & how - this could take time)
- Articulation of investment thesis (formal/written for some pm’s)
- Stress-testing of investment thesis (“Are you sure about XXX?”)
- Determination of initial position size (“Let’s start with 2% of the portfolio”)
- Discussion with equity dealers (internal colleagues but segregated reporting line etc. from pm’s) regarding liquidity, market dynamics etc
- Trade modelling / market impact assessment (by equity dealers, “Will we move the price?”)
- Determination of desired entry price range, acquisition timescale and funding availability
- Internal order placed on dealers blotter
- Confirmation that no compliance blocks (eg a colleague is an insider) exist
- Dealers start working orders with market counterparties, aiming to build the desired position in the desired timescale within x% of VWAP or similar
- Ongoing liaison between dealers and pm’s regarding market impact, price target and timescales
- Confirmation of completion of position build and post-acquisition review (formal for some pm’s, less so for others)

Some of this can be compressed to a degree - for example if your equity dealer is made aware of a sizeable line of available stock - but the intent is to buy quietly off the radar, not leaving footprints in the market".

thank you for this piece which I've only just read today as it's very insightful. I think for anyone on here wanting to understand how the sp is going to shift significantly to our advantage then this is key information (aside from the fundamentals of the tech itself).

Starbright - I'd say your scenario of II internal feedback following the SD and then possible 1:1 talks with the company is far more realistic than the negative scenario proferred by Wyndrum!

Wyndrum - I'm sure that those potential investors in attendance will be demanding absolute clarity - or as near as can be given with current data. I'd be very much surprised if AS has set himself up for a fall in front of these people by previously being deliberately ambiguous in order to lead anyone up the garden path as you seem to be suggesting might be the case. Anyway, as I've said previously on here, I think the input of the oncology experts is going to be crucial and I doubt that this has all been organised to potentially fall flat on its face.

So what’s really going on here - can anyone try to explain? I’ve held for a couple of years but to be honest I’ve lost track of all of the shenanigans over the last year

Kenny - Do you want to tell us what you’re having tea too

Ffs WYNDrum makes YET ANOTHER not so subtle reference to LFTs! Which is completely irrelevant to where we are now. The LFT scenario arose under very unique and unforeseen circumstances all round. So put that one to bed forever WYNDrum as you must know yourself it’s of no relevance.

Touk - independent, expert opinion (if favourable) should help to attract the right attention and publicity. And it should help to crystallize the thoughts of those potential investors who are in attendance. So lets wait and see what is said and what impact it has.

Touk - you ask how and why the sp will "rocket" after Science Day. I'm no ramper but I do believe that the tech will work, be brought to market and achieve considerable rewards for holders. I'm looking forward to hearing what the oncology experts have to say on Science Day as it is their input that I think will help move the sp on. So that I believe is your HOW and WHY. Of course they could fall about laughing and say it's a load of crap and they only came along for the free buffet but I somehow doubt it. Please feel free to respond??

Cheese - "folk need to get real" - why are you so in need of educating the "folk" with your wisdom?? Why not just sit back in splendid isolation and laugh at the "folk" who don't agree with your sentiments? It's glaringly obvious that you're trying/hoping to talk the price down to your aforementioned target range of £1.42 so that you can buy in - then you'll no doubt go silent as it climbs back up (on the back of others being spooked and sold up) so you can then sell. Why not simply admit the obvious!

Wyndrum - I'll take that as your agreement that the fund raise is/was a massive positive and an indication of good things to come.

That's something that I find very reassuring about where this is heading. The ease with which Avacta were able to raise funds. If you look across other companies on AIM anyone can see how difficult/impossible this is in the current financial climate. Yet Avacta managed it and at a keen price too. It's something that's completely avoided by the likes of Wyndrum and other doubters.

“Incase you didn’t know it’s the internet people pretend to be something they are not a lot of the time“

You’ve done a fantastic bit of self evaluation there!

13th - I’m thinking that their input will go some way to answering those that might wish to cast doubt on the potential of this treatment - as we’ve seen on here in the last few days?

Srings - ah so you must clearly think that the share price is artificially low (based on your perceived impact
Of the LFT on sentiment) and that it will rerate when any such mistrust is dispelled at Science Day?! Fantastic - great to see that you’re on board with this but you just haven’t worked it out for yourself yet!!

No, the title of this post doesn’t refer to any posters on here ;-) !! But I am really interested in who these opinion leaders will be that speak on the Science Day and how influential their views might be on IIs. Very powerful positives hopefully.

Wyndrum - your comment about gene therapy perfectly illustrates the difference between my genuine question (about placing) and your attempts to simply undermine. Prior to the recent RNS your concentrated approach seemed to be concerns that the trial would be a failure, missed deadlines meant bad news etc etc. Now that those arguments have been discounted you've moved on to suggesting that the technology will become obsolete before the trials are finished. what will it be next week/month I wonder???

Thanks Jimmy - a good answer to a genuine question. I imagine there might be a number of holders out there who have wondered the same thing as me, so airing questions like this on here should be seen as a positive thing (i.e. answering genuine concerns) rather than always been seen by some as attempts to undermine the share. Thank you for responding.

That's a great post Starbright. The one downside I potentially see, as with so many other AIM companies, is PIs getting screwed by a placing at a discounted rate to attract II. What are your thoughts on that possibility? I've been holding here for over two years so happy to watch this evolve in its own good time by the way.